Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis B, HBeAg Negative”

99 trials

Showing 20 of 99 results

Large-scale testing (Phase 3)Study completedNCT03903796
What this trial is testing

Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic HBV Infection
Jiangsu Hansoh Pharmaceutical Co., Ltd. 963
Testing effectiveness (Phase 2)Study completedNCT00442572
What this trial is testing

SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 21
Very early researchWithdrawnNCT05550519
What this trial is testing

A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment

Who this might be right for
Hepatitis B, Chronic
Janssen Pharmaceutica N.V., Belgium
Large-scale testing (Phase 3)Looking for participantsNCT07606950
What this trial is testing

Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B

Who this might be right for
Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B
Fujian Shengdi Pharmaceutical Co., Ltd. 540
Post-approval studies (Phase 4)Study completedNCT02570191
What this trial is testing

PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV)

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 60
Not applicableLooking for participantsNCT05661786
What this trial is testing

Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase

Who this might be right for
Chronic Hepatitis b
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 4,500
Testing effectiveness (Phase 2)Study completedNCT01524679
What this trial is testing

Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen

Who this might be right for
Chronic Hepatitis B
Johannes Gutenberg University Mainz 170
Testing effectiveness (Phase 2)Ended earlyNCT02604199
What this trial is testing

A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B
Arrowhead Pharmaceuticals 58
Large-scale testing (Phase 3)WithdrawnNCT01204827
What this trial is testing

Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath Test

Who this might be right for
Chronic Hepatitis B
Hadassah Medical Organization
Large-scale testing (Phase 3)Study completedNCT00661076
What this trial is testing

ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 10
Post-approval studies (Phase 4)UnknownNCT02893124
What this trial is testing

The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 200
Not applicableStudy completedNCT01734018
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 50
Post-approval studies (Phase 4)Study completedNCT00436163
What this trial is testing

Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 39
Not applicableUnknownNCT05490836
What this trial is testing

Functional Cure Rate of Peg-IFNα-2b Combined With TAF in HBeAg Negative CHB Patients

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 200
Not applicableStudy completedNCT01581554
What this trial is testing

Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B e Antigen PositiveChronic Hepatitis B e Antigen Negative
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 15
Post-approval studies (Phase 4)UnknownNCT00917761
What this trial is testing

Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
National Taiwan University Hospital 300
Large-scale testing (Phase 3)Study completedNCT01237496
What this trial is testing

Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 17
Post-approval studies (Phase 4)Ended earlyNCT00460850
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 60
Not applicableStudy completedNCT01730508
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 978
Large-scale testing (Phase 3)Study completedNCT00035789
What this trial is testing

A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Negative for Hepatitis B e Antigen

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation